ADRB2 and asthma: Significant loss in PP2A activity was observed on the plasma membranes as well as endosomes in the asthmatic HASMCs (Fig 5b) compared to non-asthmatic HASMCs (Fig 5b) suggesting that reduction in phosphatase activity and loss in resensitization may underlie βAR dysfunction in asthma HASM.